Olaratumab Exerts Antitumor Activity in Preclinical Models of Pediatric Bone and Soft Tissue Tumors through Inhibition of Platelet-Derived Growth Factor Receptor α
Crossref DOI link: https://doi.org/10.1158/1078-0432.CCR-17-1258
Published Online: 2018-02-14
Published Print: 2018-02-15
Update policy: https://doi.org/10.1158/crossmark_policy
Lowery, Caitlin D.
Blosser, Wayne
Dowless, Michele
Knoche, Shelby
Stephens, Jennifer
Li, Huiling
Surguladze, David
Loizos, Nick
Luffer-Atlas, Debra
Oakley, Gerard J. III
Guo, Qianxu
Iyer, Seema
Rubin, Brian P.
Stancato, Louis